Invited Commentary on: Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India Beyond R0: Balancing Oncologic Benefit and Surgical Burden in Metastatic GIST

Journal of Gastrointestinal Surgery · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles